LINC00460 and cancer: As shown in Figure 3, LINC00460 overexpression is significantly related to high risk of death in eight different tumors, analyzed in a single model (CESC, GBM, HNSC, KIRC, LGG, LUAD, PAAD and SARC) (log2HR>1; p<0.05) (Figure 3A), and with high risk of relapse in four cancers (KIRC, LUAD, READ and SARC) (log2HR>1; p<0.05) (Figure 3B).